AVR 5.71% $13.20 anteris technologies ltd

HSV vaccine Phase 1 Results?, page-6

  1. 3,092 Posts.
    lightbulb Created with Sketch. 69
    Apologies Spangers, I was the one who thought we'd see them prior to the Bio conference. Two weeks in a row I was expecting them to be released and two weeks in a row I was wrong. Given my recent track record you should have no confidence in my next prediction although I think now we'll see them in the second half of July…….. Either way I am very confident for reasons I've stated previous that they'll be extremely encouraging. Have a look at BNO's recent ann re. their partnership with Merck and you'll get an idea of what positive results may entail. Cheers.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.